An observational study in Preterm Infant Development, Preterm Infant Health and Prematurity Complications, sponsored by University Hospital of Cologne. Recruiting at 1 site in Germany. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-24.
Sponsored by University Hospital of Cologne · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 68 studies in Premature Birth with a site in Germany — 11 open to participants now, 13 under way, 1 of them phase 3. Premature Birth · Germany.
Among the 68 studies in Premature Birth with a site in Germany, this one is the 5th largest by planned enrollment of the 28 observational ones that give a count, is the only one that started in 2026, is one of 28 observational ones, reaches primary completion later than 12 of the 12 other live ones, and was the 68th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →11 of the 68 studies in Premature Birth with a site in Germany are open now. Recruiting first, the newest first:
Global Foundation for the Care of Newborn Infants · Sites in Germany
Ages 0–18 · Healthy volunteers
University of Cologne · Sites in Germany
Ages 1 days–7 days · Healthy volunteers
Goethe University · Sites in Germany
Healthy volunteers
Leiden University Medical Center · Sites in Germany, Austria, Belgium and 16 more countries
Ages up to 32 wk
University Hospital Tuebingen · Sites in Germany
Ages 28 wk–34 wk · Healthy volunteers
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: Up to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
68 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 8 · Phase 4 2
First in 1996; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,300 is above the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 98 across the 40 interventional studies, 225 across the 28 observational. Of the 36 that completed or were terminated, 6 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 68 have an industry lead sponsor. The 10 most frequent:
University Hospital of Cologne is the lead sponsor of 42 studies on the registry; 15 are open to participants now.
University Hospital of Cologne has 3 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
4 of the studies in Premature Birth with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03168516Phase 3University Hospital TuebingenEffects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants | 2026-12 |
| NCT06345664University Hospital TuebingenInterdisciplinary E-health Based Follow-up of Preterm Born Children | 2026-12 |
| NCT05975203University of CologneContinuous Delivery Room Skin-to-skin-study for Moderate and Late Preterm Infants | 2026-12-31 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 68 studies in Premature Birth with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The Neo-Life project aims to establish a prospective neonatal data and biobank to investigate factors influencing the short- and long-term development of very preterm infants. Advances in neonatal care have significantly improved survival rates of infants born with a gestational age of less than 32 weeks and/or a birth weight below 1500 g. However, these infants remain at high risk for multiple complications affecting neurological, pulmonary, cardiovascular, renal, and other organ systems, which may lead to long-term morbidity and reduced quality of life. Identifying early risk and protective factors is therefore essential to improve outcomes and develop targeted interventions.
The primary objective of the project is the prospective and structured collection of clinical data as well as biological samples within a standardized interdisciplinary follow-up program for preterm infants. The study aims to identify biological, clinical, and environmental factors associated with the development and long-term outcomes of different organ systems.
The study population includes infants born with a gestational age of less than 32 weeks and/or a birth weight below 1500 g who receive care at the perinatal center of the University Hospital Cologne. Participation requires informed consent from the parents or legal guardians. There are no specific exclusion criteria. Participants will be followed within the established preterm follow-up program over several years, allowing longitudinal assessment of clinical outcomes and developmental trajectories. Primary outcome is survival without impairment (e.g. neurocognitive, pulmonal, cardiovascular, renal) at the age of 5 years. Secondary outcomes include duration of breastfeeding, nutritional status, body mass index, and parental stress and bonding. In addition, biological samples will be collected to enable the creation of epigenetic, gene expression, and cytokine profiles. These data will contribute to the identification of predictive biomarkers that may help stratify risk and guide individualized preventive or therapeutic strategies in preterm infants.
By combining comprehensive clinical data with biological samples in a dedicated data and biobank, the Neo-Life project aims to generate a valuable resource for translational research. The findings are expected to improve understanding of the mechanisms underlying organ development and long-term health in preterm infants and to support the development of early interventions that may prevent or mitigate adverse outcomes.
Infants born with a gestational age of less than 32 weeks and/or a birth weight below 1500 g who receive care at the perinatal center of the University Hospital Cologne
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Preterm infants born \<32 weeks' gestational age and/or with a birth weight \<1500 g who receive care at the perinatal center of the University Hospital Cologne.
Survival without cognitive impairment
Neurocognitive Impairment is defined as Bayley Scales of Infant Development III (Bayley - III) cognitive score less than 84.
Time frame: at the age of 5 years
Survival without impaired motor function
Motor function impairment is defined as Gross Motor Function Classification System (GMFCS) level of 2 or higher.
Time frame: at the age of 5 years
Survival without visual impairment
Visual impairment is defined as need of visual aid or blindness.
Time frame: at the age of 5 years
Survival without hearing impairment
Hearing impairment is defined as hearing with amplification or hearing loss despite amplification.
Time frame: at the age of 5 years
Survival without seizures
The occurrence of seizures is assessed during follow-up visits.
Time frame: at the age of 5 years
Duration of breast feeding
Duration of breast feeding is assessed during follow-up visits.
Time frame: 2 years
Weight gain
Weight progression is assessed using percentile curves (Fenton, WHO). This includes assessing wether the weight trajectory lies within the normal range (10th - 90th percentile) and wether percentile shifts occur.
Time frame: birth to the age of 18 years
Growth in length/height
Growth in length/height is assessed using percentile curves (Fenton, WHO). This includes assessing wether the length/height trajectory lies within the normal range (10th - 90th percentile) and wether percentile shifts occur.
Time frame: birth to the age of 18 years
General Movements
Early infant development will be assessed using General Movements Assessment by Prechtl. It is a validated diagnostic tool for the functional assessment of the young nervous system.
Time frame: corrected 3 months of age
Maternal depression
The German long form of the Center for Epidemiological Studies Depression Scale (CES-D) will be used to assess maternal depression. The self-report questionnaire consists of 20 questions and its score ranges from 0 to 60. A score of 15 or higher indicates a risk of depression.
Time frame: at the corrected age of 35-40 weeks' gestational age, at the corrected age of 6 months and at the corrected age of 24 months
Post-traumatic Stress
Post-traumatic stress is assessed with the impact of event scale - revised (IES-R). The self-report questionnaire consists of 22 questions and includes 3 sub-scales (intrusion, avoidance and hyperarousal). The overall score ranges from -4,36 to 2,99. A result above 0 is interpreted to indicate a risk of post-traumatic stress disorder.
Time frame: at the corrected age of 6 months
Parental Bonding
Parental Bonding is assessed using the parental bonding questionnaire (PBQ), which consists of 25 items and includes 4 sub-scales (impaired bonding, rejection and anger, anxiety about care, risk of abuse). A higher the score indicates a higher risk of a disorder in each area of the sub-scale.
Time frame: corrected age of 6 and 24 months
Social Support
Social support is assessed using the short version of the German questionnaire for social support (Fragebogen zur sozialen Unterstützung, questionnaire on social support) scale (F-SozU K-22). The questionnaire includes 22 items and its scale ranges from a minimum of 22 points to a maximum of 110 points. The higher the score, the better the subjectively perceived or anticipated support.
Time frame: at the corrected age of 35-40 weeks' gestational age and at the corrected age of 24 months
Plan to share: No — As the participants in this study are minors, special attention will be paid to the protection of personal data. Therefore, the information and consent documents provided to the legal guardians contain a statement assuring that no data will be disclosed to third parties.
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Mar 2036, 120 months later.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 120 months is above that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital of Cologne